ripekg:evaluation/RIPEAFD472E5D4DA5C642 |
prov:wasInformedBy |
ripekg:evidence-aggregation/RIPEAFD472E5D4DA5C642 |
ripekg:evidence-aggregation/RIPEAFD472E5D4DA5C642 |
rdf:type |
rdfs:Resource |
ripekg:evidence-aggregation/RIPEAFD472E5D4DA5C642 |
rdf:type |
owl:Thing |
ripekg:evidence-aggregation/RIPEAFD472E5D4DA5C642 |
rdf:type |
ripe:EvidenceAggregationEvidence aggregation |
ripekg:evidence-aggregation/RIPEAFD472E5D4DA5C642 |
rdf:type |
tido:Activity |
ripekg:evidence-aggregation/RIPEAFD472E5D4DA5C642 |
prov:startedAtTime |
2025-11-13T16:11:34.647831Z |
ripekg:evidence-aggregation/RIPEAFD472E5D4DA5C642 |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI 1.0.0 |
ripekg:evidence-aggregation/RIPEAFD472E5D4DA5C642 |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI |
ripekg:evidence-aggregation/RIPEAFD472E5D4DA5C642 |
tido:contributesTo |
ripekg:research-integrity-assessment/RIPEAFD472E5D4DA5C642 |
ripekg:publication-details/RIPEAFD472E5D4DA5C642Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAFD472E5D4DA5C642 |
ripekg:registry-evidence/RIPEAFD472E5D4DA5C642 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAFD472E5D4DA5C642 |
ripekg:retraction-notice/17286Expression of phosphodiesterase type 5A in human spermatozoa and influence of its inhibition on motility and functional sperm parameters |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAFD472E5D4DA5C642 |
ripekg:study-design-evidence/RIPEAFD472E5D4DA5C642 |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAFD472E5D4DA5C642 |